SEC EDGAR filings, ownership reports, and insider transactions for L.P. Frazier Life Sciences X.
Recent SEC filings for L.P. Frazier Life Sciences X including SCHEDULE 13D/A, 4, SC 13D/A and more.
| Form type | Document | Filing | Description | Filing date | Reporting date | File number(s) |
|---|---|---|---|---|---|---|
| SCHEDULE 13D/A | Open SCHEDULE 13D/A document | View SEC filing for SCHEDULE 13D/A | 04 Nov 2025 | |||
| 4 | Open 4 document | View SEC filing for 4 | 30 Sep 2025 | 26 Sep 2025 | 001-42272 | |
| 4 | Open 4 document | View SEC filing for 4 | 17 Sep 2025 | 17 Sep 2025 | 001-41365 | |
| SCHEDULE 13D/A | Open SCHEDULE 13D/A document | View SEC filing for SCHEDULE 13D/A | 20 Aug 2025 | |||
| SC 13D/A | Open SC 13D/A document | View SEC filing for SC 13D/A | SC 13D/A | 17 Dec 2024 | ||
| 4 | Open 4 document | View SEC filing for 4 | 4 | 17 Sep 2024 | 16 Sep 2024 | 001-42272 |
| 3 | Open 3 document | View SEC filing for 3 | 3 | 12 Sep 2024 | 12 Sep 2024 | 001-42272 |
| 4/A | Open 4/A document | View SEC filing for 4/A | 31 May 2024 | 04 Apr 2024 | 001-41365 | |
| 4 | Open 4 document | View SEC filing for 4 | 08 Apr 2024 | 04 Apr 2024 | 001-41365 | |
| SC 13D/A | Open SC 13D/A document | View SEC filing for SC 13D/A | SC 13D/A | 21 Feb 2024 | ||
| SC 13D/A | Open SC 13D/A document | View SEC filing for SC 13D/A | SC 13D/A | 15 Aug 2023 | ||
| SC 13D/A | Open SC 13D/A document | View SEC filing for SC 13D/A | SC 13D/A | 09 Jun 2023 | ||
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 03 May 2022 | 03 May 2022 | 001-41365 |
| 3 | Open 3 document | View SEC filing for 3 | FORM 3 SUBMISSION | 28 Apr 2022 | 28 Apr 2022 | 001-41365 |
| 3/A | Open 3/A document | View SEC filing for 3/A | OWNERSHIP DOCUMENT | 17 Dec 2020 | 08 Dec 2020 | 001-39765 |
| 4 | Open 4 document | View SEC filing for 4 | OWNERSHIP DOCUMENT | 11 Dec 2020 | 11 Dec 2020 | 001-39765 |
| 3 | Open 3 document | View SEC filing for 3 | OWNERSHIP DOCUMENT | 08 Dec 2020 | 08 Dec 2020 | 001-39765 |
| D | Open D document | View SEC filing for D | 17 Dec 2019 | 021-355633 |
L.P. Frazier Life Sciences X files with the SEC under CIK 0001790879. This page aggregates EDGAR filings and related ownership activity.